The hyper-IgM syndrome: 13 Observations;Le syndrome d'hyper-IgM: 13 Observations

Presse Medicale

Volumn 32, Issue 12, 2003, Pages 544-549

  Bejaoui, Mohamed ^a   Mellouli, Fethi ^a   Chouanine, Riadh ^a   Dellagi, Koussay ^b   Barbouche, Mohamed R ^b  

^a CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

^b PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BURKITT LYMPHOMA; CELLULAR IMMUNODEFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIUM; FEMALE; GASTROINTESTINAL INFECTION; HUMAN; HYPERIMMUNOGLOBULINEMIA M; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MALE; NEUROLOGIC DISEASE; NEUTROPENIA; ONSET AGE; PNEUMOCYSTOSIS; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS; SKIN INFECTION; TUNISIA;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; IGG DEFICIENCY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; MALE; NEUTROPENIA; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 0037471879     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Israel-Asselain R, Burtin P, Chebat J. Un trouble biologique nouveau: l'agammaglobulinémie avec b2 macroglobulinémie (un cas). Bull Soc Med Hop Paris 1960; 76:519.
2. Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodef Rev 1992; 3 :101-22.
3. Durant JR, Eisner JW, Tassoni IM, Smalley RV. "Asymptomatic" type I dysgammaglobulinemia in siblings. Ann Intern Med 1968; 91:464-8.
4. WHO. Primary immunodeficiency diseases. Clin Exp Immunol 1997; 109, suppl 1:1-25.
5. Revy P, Muto T, Levy Y et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 2000; 102:565-75.
6. Brahmi Z, Lazaws KH, Hodes ME, Baehre RL. Immunologic studies of three familiy members with the immunodeficiency with hyper IgM syndrome. J. Clin Immunol 1983; 3:127-34.
7. Levy J, Espanol-Boren T, Thomas C et al. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr 1997; 131:47-54.
8. Béjaoui M, Barbouche MR, Sassi A, Bouguerra A, Dellagi K. Les déficits immunitaires primitifs en Tunisie: étude de 152 cas. Arch Pediatr 1997; 4:827-31.
9. Kallel K, Belhadj S, Zribi A, Chalker E. La pneumocystose: maladie peu fréquente en Tunisie? Med Mal Infect 1998; 28:311-12.
10. Abouya YL, Beaumel A, Lucas et al. Pneumocystis carinii pneumonia, an uncommun cause of death in african patients with AIDS. Am Rev Resp Dis 1992; 145:617-20.
11. M'boussa J, Kaoudi E, Kikolo J et al. Pneumocystoses observées au Congo chez les malades atteints de SIDA. Faible dissémination du parasite en Afrique. Rev Pneumol Clin 1991; 47:39-42.
12. Filipowich AH, Heinitz KJ, Robinson LL, Frizzera G. The immunodeficiency cancer registry. A research resource. Am J Pediatr Hematol Oncol 1987; 9:183-4.
13. Ameratunga R, Lederman HM, Sullivan KE et al. Defective antigene-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr 1997; 131:147-50.
14. Grewal IS, XU J, Flavell RA. Impairment of antigen-specific T-cell primary in mice licking CD40 ligand. Nature 1995; 378:617-20.
15. Wiley JA, Harmsen AG. CD40 ligand is required for resolution of pneumocystis Carinii pneumonia in mice. J. Immunol 1995; 155:3525-9.
16. Notarangelo LD, Peitsch ML. CD40 L base: a database of CD40 L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 1996; 17:511-16.
17. Seyama K, Nonoyama S, Gangsaas I et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 1998; 92:2421-34.
18. Muramatsu M, Sankaranand VS, Anant S et al. Class switch recombination and somatic hypermutation require activation-induced cytidine deaminase (AID), a member of RNA-editing cytidine deaminase family. Cell 2000; 102:553-63.
19. Andrews FJ, Katz F, Jones A, Smith S, Finn A. CD40 ligand deficiency presenting as unresponsive neutropenia. Arch Dis Child 1994; 74:458-9.
20. Iseki M, Anzo M, Yamashita N, Matsuo N. Hyper IgM immunodeficiency with disseminated cryptococcosis. Acta Pediatr 1994; 83:780-2.
21. Roifman CM, Lederman HM, Stein LD, Levison H, Gelfand EW. Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am J Med 1985; 79:171-4.
22. Thomas C, De Saint-Basile G, Le Deist F et al. Brief report: correlation of X-linked hyper-IgM syndrome by allogenic bone marrow transplantation. N Engl J Med 1995; 333:426-9.
23. Hansel TT, Hoeney MR, Thompson RA. Primary hypogammaglobulinemia and arthritis. Br Med J 1987; 295:174-5.
24. Hermaszewski RA, Webster ABD. Primary hypogammaglobulinemia: a survey of clinical manifestations and complications. Quart J Med 1993; 86:31-41.
25. Prasad RVSK, Keserwala HH, Papageorgiou PS. Control of arthritis associated with congenital agammaglobulinemia by high doses of exogenous gamma globulin. Pediatrics 1980; 66/327-8.